Palantir (PLTR) Stock Price Prediction: Revenue strength collides with a weakening tape
What moved PLTR stock
Palantir (PLTR) is still digesting its post-earnings reset. The stock is down 4.56% over 24 hours at $159.56, with the intraday range stretching from $167.72 to $158.73. That puts PLTR shares below the 7-day SMA at $165.40, the 20-day SMA at $170.13 and the 50-day SMA at $185.60, while the 200-day SMA sits slightly below at $157.83. The read-through is straightforward: the market is still repricing momentum after the latest earnings release, even as the long-term trend has not fully broken.
What the latest earnings print changed
The fundamental backdrop remains strong enough to keep analysts engaged. Palantir reported Q3 2026 revenue growth of 96% year over year and U.S. commercial revenue growth of 148% year over year, according to Palantir IR on November 2, 2026. CNBC also reported adjusted earnings of 44 cents per share versus 41 cents expected, with revenue of $2.31 billion versus $2.18 billion consensus. That combination matters because it shows the business is still outgrowing expectations, but the share price reaction shows investors are now scrutinizing the quality of that growth more closely, including softer contract value per booking figures and non-U.S. commercial booking growth highlighted by CNBC.
Analyst targets remain high, but they are not the same as near-term trading levels
Phillip Securities raised its Palantir target to $248 from $215 and kept a Buy rating, citing the company’s strong revenue growth, high gross margin and full-year 2026 expectations for $8.53 billion in revenue and $5.25 billion in adjusted operating income. Barclays raised its target to $273 from $265 and kept an Overweight rating, while Morgan Stanley raised its target to $233 from $205 and kept an Equalweight rating. These targets frame a wide range of longer-horizon views, but they do not override the current tape. The gap between price and targets is large; the gap between price and momentum is also large.
Technical structure: support is close, but trend is still fragile
The chart is not broken, but it is not healthy either. PLTR’s moving averages are stacked bearishly, with MA7 below MA20 and MA20 below MA50, and the stock trading well under both the 20-day and 50-day lines. RSI at 36.28 sits in neutral territory, but it is close enough to oversold to matter if selling pressure slows. MACD is negative, the histogram is flat at 0.0000, and the stochastic readings are low, which fits a market that is under pressure but not in a clean capitulation.
The levels that matter are clear. Immediate support is $156.29, with stronger support at $153.01. The 200-day average at $157.83 is nearby and could act as a short-term pivot if the stock stabilizes. On the upside, $162.00 is the pivot, $165.28 is immediate resistance, and $170.99 is the stronger barrier. Above that, the 20-day SMA at $170.13 becomes a key reclaim level.
Positioning and flow: new exposure is building, but sellers are still pressing
Binance perpetual futures show a mixed setup. Funding is neutral at 0.0000%, which says neither side is paying up for leverage. Open interest is 44,119.41 contracts, with daily open interest value at $7.51 million and a 24-hour increase of 6.81%, indicating fresh position building. That does not tell you direction by itself. The directional clue is in the split: global Binance accounts are 48.0% long and 52.0% short, while top-trader accounts are 54.5% long and 45.5% short. Against that, the taker buy/sell ratio of 0.7320 points to aggressive selling pressure in the near term.
The setup from here
The key question is whether PLTR can hold the 200-day area and defend the $156.29 to $153.01 support band after the earnings-driven reset. If it does, the setup shifts from de-rating to consolidation, especially with analysts still pointing materially higher. If it fails, the next move is likely a deeper test of the lower Bollinger Band at $149.19, with volatility already elevated at an ATR(14) of $7.83.
What matters most now is not whether Palantir can keep growing — the company clearly is — but whether the market is willing to keep paying for that growth after the latest run-up and post-earnings shakeout.